Life Science Today

A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Revance
Velocity + MedPharmics
Arsenal
SpringWorks Link 1, Link 2, Link 3

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Novo + Forma
Sanofi
Boehringer Ingelheim
Arcturus


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Alcon + Aerie
Novartis + Sandoz
Labcorp + RWJBH

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Bluebird
Endo & Pharmacies
Genentech + Jemincare
Merck + Orna

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Spending that COVID money, brain money, Irish money, and another oncology approval.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Pfizer
Cerevel
Abbott
AstraZeneca + Daiichi Sankyo

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives?
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Zymergen + Ginkgo
Cassava
Teva

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As

Find out more at
https://LifeScienceTodayPodcast.com

Story References
ZyVersa
Incyte
Revolution
Frontera
CAMP4
ForSight
Auron

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Vertex + ViaCyte
Theravance Biopharma
Merck + Orion
Pliant Therapeutics
Qiming

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

FEED DROP - Clinical Research Evolved

Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.

Find Out More
Dan Agroskin
Clinical Research Evolved
Noah Goodson, PhD
John Reites
Kyle Ricketts




About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Double acquisition, private money, affordable deals, and a surprising $70M launch

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Galapagos + CellPoint + AboundBio
Radius
Ipsen + Epizyme
DEM Bio

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.